Darnax Pharma Private Limited
About Darnax Pharma Private Limited
Data last updated:
Darnax Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2011PTC220735. Its GSTIN is 27AADCD9462B1ZQ (Maharashtra).
The company has an authorised share capital of ₹21 Lakh and a paid-up capital of ₹21 Lakh. It is led by directors including Rekha Naresh Hiran and Dariyadevi Kantilal Hiran.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.42 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.69 Cr (net margin 4.8%) and EBITDA of ₹5.17 Cr (EBITDA margin 14.6%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address1616 One Lodha Place, Senapati Bapat Marg Lower Parel, Mumbai, Maharashtra, India – 400013
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Darnax Pharma Private Limited
The main business activity of Darnax Pharma is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Darnax Pharma Private Limited FY 2025 filings available
Darnax Pharma Private Limited reported revenue of ₹35.42 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Darnax Pharma Private Limited
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Darnax Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.17 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.69 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Darnax Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Darnax Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Darnax Pharma Private Limited
Darnax Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| A N Pharmaceuticals Private Limited | ₹35.77 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Salem Institute of Medical Sciences and Hospitals Private Limited | ₹35.74 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Salem, Tamil Nadu, India |
| Aashish Bio Business Private Limited | ₹35.61 Cr (FY 2025) | •••• | •••• | 109.0% | •••• | Telangana, India |
| Mukesh Pharma Private Limited | ₹35.54 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Noida, Uttar Pradesh, India |
| Rasayan Marketing Private Limited | ₹35.54 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Hyderabad, Telangana, India |
| Darnax Pharma Private Limited this company | ₹35.42 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Mumbai, Maharashtra, India |
| Integrity Pharmachem Private Limited | ₹35.33 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Vadodara, Gujarat, India |
| Pro Young International Private Limited | ₹35.27 Cr (FY 2018) | •••• | •••• | 143.0% | •••• | Hyderabad, Telangana, India |
| Green Apple Health Care Private Limited | ₹35.17 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Pune, Maharashtra, India |
| Abhay Trading Private Limited | ₹35.1 Cr (FY 2022) | •••• | •••• | -43.0% | •••• | Mumbai, Maharashtra, India |
| Emjay Capfin Private Limited | ₹35.07 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Guwahati, Assam, India |
Peers are the five companies nearest above and the five nearest below Darnax Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Darnax Pharma Private Limited
Darnax Pharma Private Limited is audited by B.L. DASHARDA & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B.L. DASHARDA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Darnax Pharma Private Limited
Darnax Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rekha Naresh Hiran Also directs: DNR Pharma LLP | Director | 01 Mar 2018 | 8 Years 7 Months | Current |
| Naresh Kantilal Hiran Also directs: DNR Pharma LLP | Additional Director | 07 Feb 2023 | 3 Years 8 Months | Current |
| Dariyadevi Kantilal Hiran | Director | 09 Aug 2011 | 15 Years 2 Months | Current |
Ownership and Shareholding of Darnax Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Darnax Pharma Private Limited
Darnax Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Darnax Pharma Private Limited
Employment history and EPFO contributions of people linked to Darnax Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Darnax Pharma Private Limited
Darnax Pharma Private Limited has 4 board changes on record since 2011: 3 appointments and 1 cessation. The latest: Naresh Kantilal Hiran was appointed as Additional Director on 07 Feb 2023.
Credit Ratings, Litigation & Regulatory Alerts for Darnax Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Darnax Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Darnax Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Darnax Pharma Private Limited
Darnax Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCD9462B1ZQ | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Darnax Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Darnax Pharma Private Limited
Darnax Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 August 2011 (15+ years old) and is registered under CIN U24100MH2011PTC220735.
Darnax Pharma reported revenue of ₹35.42 Cr for FY 2025 (down 2% YoY).
Darnax Pharma has 3 current directors:
- Rekha Naresh Hiran - Director
- Naresh Kantilal Hiran - Additional Director
- Dariyadevi Kantilal Hiran - Director
Darnax Pharma reported a net profit of ₹1.69 Cr (net margin 4.8%) and EBITDA of ₹5.17 Cr (EBITDA margin 14.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Darnax Pharma is -4% over three years and 10% over five years. In the latest year (FY 2025) revenue fell 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Darnax Pharma is 27AADCD9462B1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Darnax Pharma is U24100MH2011PTC220735. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Darnax Pharma was incorporated on 09 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Darnax Pharma by revenue are A N Pharmaceuticals Private Limited, Salem Institute of Medical Sciences and Hospitals Private Limited, Aashish Bio Business Private Limited, Mukesh Pharma Private Limited, Rasayan Marketing Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Naresh Kantilal Hiran was appointed as Additional Director on 07 Feb 2023. Naresh Kantilal Hiran ceased to be Director on 31 Mar 2019. Rekha Naresh Hiran was appointed as Director on 01 Mar 2018. Darnax Pharma has 4 board changes on record in total.
The registered office of Darnax Pharma is at 1616 One Lodha Place, Senapati Bapat Marg Lower Parel, Mumbai, Maharashtra, India – 400013.